FDA office of operations & center for drug evaluation and research FDA hiring pilot phase 2 support
Ended Awarded Last action
- Contract number
- 75F40120F80182
- Awardee
-
The Mitre Corporation UEI DMHDNDCPWUD1 Part of The Mitre Corporation
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,265,014
Award facts
- Opportunity
-
- CMS Alliance to Modernize Healthcare (CAMH) Federally Funded Research and Development Center (FFRDC) Solicitation · Posted May 23, 2017
- Contract value 84% obligated
-
- $1,265,014.00 Current, with exercised options
- $1,500,005.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- West McLean, VA 22102, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $450,709 | |
| Original award | $814,305 |
About this award
The Food and Drug Administration issued a delivery order to The Mitre Corporation on May 14, 2020, under a parent indefinite delivery contract for FDA hiring pilot phase 2 support, with a ceiling value of $1.5 million and an ultimate completion date of June 13, 2022.
Place of performance is West McLean, VA. The order is priced on a cost-plus-fixed-fee basis with no set-aside.
Service Contract Inventory data reflects actual government-invoiced labor across the order's performance period. FY2021 recorded $783 thousand invoiced across 2.3 FTEs and 4,705 contractor hours at a derived rate of $166.34 per hour. FY2022 activity declined to $213 thousand invoiced, 0.4 FTEs, and 906 contractor hours at $235.18 per hour. Mitre self-performed all reported hours with no subcontractor involvement. The derived hourly rate rose year-over-year from FY2021 to FY2022.
Quick answers
Who was awarded contract 75F40120F80182?
75F40120F80182 was awarded to The Mitre Corporation by Food and Drug Administration (Department of Health and Human Services) on May 14, 2020.
How much is contract 75F40120F80182 worth?
The government has obligated $1,265,014 on 75F40120F80182. Its potential value, with all options, is $1,500,005.
Is contract 75F40120F80182 an order under another contract?
Yes. 75F40120F80182 is a delivery order under 75FCMC18D0047, an indefinite delivery contract.
Was contract 75F40120F80182 competed?
The extent of competition for 75F40120F80182 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award